Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound

Hepatology

Volumn 51, Issue 6, 2010, Pages 2020-2029

  Vilana, Ramón ^a,b   Forner, Alejandro ^a,b   Bianchi, Luis ^a,b   Garcìa Criado, Ángeles ^a   Rimola, Jordi ^a,b   De Lope, Carlos Rodrìguez ^a   Reig, Marìa ^a,b   Ayuso, Carmen ^a,b   Brú, Concepció ^a,b   Bruix, Jordi ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HISTOLOGY; HUMAN; INTRAHEPATIC CHOLANGIOCARCINOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ULTRASOUND;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHOSPHOLIPIDS; SULFUR HEXAFLUORIDE;

EID: 77952688584     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23600     Document Type: Article

References (32)

1. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999;341:1368-1378.
2. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005;366:1303-1314.
3. Shaib Y, El-Serag H. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24:115-125.
4. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. HEPATOLOGY 2008;48:308-321. (Pubitemid 351975555)
5. Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 2007;102:1016-1021. (Pubitemid 46698225)
6. Organ distribution: allocation of livers - liver transplant candidates with hepatocellular carcinoma (HCC). United Network for Organ Sharing Website. Available at: http://www.unos.org/policiesandbylaws/policies.asp?resourcestrue Revised March 3, 2009.
7. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430.
8. Bruix J, Sherman M. Management of hepatocellular carcinoma. HEPATOLOGY 2005;42:1208-1236.
9. Forner A, Vilana R, Ayuso C, Bianchi L, Sole M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. HEPATOLOGY 2008;47:97-104. (Pubitemid 351171046)
10. Chen LD, Xu HX, Xie XY, Lu MD, Xu ZF, Liu GJ, et al. Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol 2008;81:881-889.
11. D'Onofrio M, Vecchiato F, Cantisani V, Barbi E, Passamonti M, Ricci P, et al. Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging. Radiol Med 2008;113:76-86. (Pubitemid 351387208)
12. Li R, Guo Y, Hua X, He Y, Ding J, Guo A, et al. Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT. J Clin Ultrasound 200;35:109-117.
13. Celli N, Gaiani S, Piscaglia F, Zironi G, Camaggi V, Leoni S, et al. Characterization of liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol 2007;19:3-14. (Pubitemid 46066862)
14. Xu HX, Liu GJ, Lu MD, Xie XY, Xu ZF, Zheng YL, et al. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 2006;34:261-272.
15. Xu HX, Lu MD, Liu GJ, Xie XY, Xu ZF, Zheng YL, et al. Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med 2006;25:23-33.
16. Chen LD, Xu HX, Xie XY, Xie XH, Xu ZF, Liu GJ, et al. Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol 2010;20:743-753.
17. Marti-Bonmati L, Talens A, del Olmo J, de Val A, Serra MA, Rodrigo JM, et al. Chronic hepatitis and cirrhosis: evaluation by means of MR imaging with histologic correlation. Radiology 1993;188:37-43. (Pubitemid 23183096)
18. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008;371:838-851.
19. Ito K, Mitchell DG, Hann HW, Kim Y, Fujita T, Okazaki H, et al. Viral-induced cirrhosis: grading of severity using MR imaging. AJR Am J Roentgenol 1999;173:591-596. (Pubitemid 29395273)
20. Mortele KJ, Ros PR. MR imaging in chronic hepatitis and cirrhosis. Semin Ultrasound CT MR 2002;23:79-100.
21. Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. HEPATOLOGY 2003;38:1034-1042. (Pubitemid 37221687)
22. Lencioni R, Piscaglia F, Bolondi L. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol 2008;48:848-857.
23. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002;51(Suppl 6):VI1-VI9. (Pubitemid 35216840)
24. Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med 2008;29:28-44. (Pubitemid 351294171)
25. Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 2009;29:683-700.
26. Kim SJ, Lee JM, Han JK, Kim KH, Lee JY, Choi BI. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. AJR Am J Roentgenol 2007;189:1428-3144.
27. Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, et al. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. HEPATOLOGY 2009;50:791-798.
28. Fan ZM, Yamashita Y, Harada M, Baba Y, Yamamoto H, Matsukawa T, et al. Intrahepatic cholangiocarcinoma: spin-echo and contrast-enhanced dynamic MR imaging. AJR Am J Roentgenol 1993;161:313-317. (Pubitemid 23224794)
29. Hamrick-Turner J, Abbitt PL, Ros PR. Intrahepatic cholangiocarcinoma: MR appearance. AJR Am J Roentgenol 1992;158:77-79.
30. Gabata T, Matsui O, Kadoya M, Yoshikawa J, Ueda K, Kawamori Y, et al. Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 1998;23:309-313. (Pubitemid 28213309)
31. Maetani Y, Itoh K, Watanabe C, Shibata T, Ametani F, Yamabe H, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 2001;176:1499-1507. (Pubitemid 32510270)
32. Wilson SR, Kim TK, Jang H-J, Burns PN. Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol 2007;189:W7-W12.